Drug delivery and pharmacotherapy for dry eye disease

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 2, 2012, Pages 42-46

  Wagh, Vijay D ^a   Apar, Dipak U ^a   Surana, Sanjay J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Artificial tears; Cyclosporine A; Dry eye disease

Indexed keywords

ALPHA2 INTERFERON; AMBROXOL; ANDROGEN; ANTIINFLAMMATORY AGENT; ARTIFICIAL TEAR; AYURVEDIC DRUG; BENZALKONIUM CHLORIDE; BETHANECHOL; BOTULINUM TOXIN; BROMHEXINE; CARBACHOL; CARBOMER; CELLULOSE DERIVATIVE; CHLORBUTOL; CORTICOSTEROID; CYCLOSPORIN A; DRUG PRESERVATIVE; ESTROGEN; EYE DROPS; FLUOROMETHOLONE; LOTEPREDNOL; LUBRICATING AGENT; MACROGOL 400; POLYMER; POLYVINYL ALCOHOL; POVIDONE; TETRACYCLINE; THIOMERSAL; UNINDEXED DRUG; ZIDOVUDINE;

ACUPUNCTURE; AYURVEDA; CATARACT; CAUTERIZATION; DIATHERMY; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRY EYE; ENDOTAMPONADE; HUMAN; HUMIDIFIER; HYDROPHILIC CONTACT LENS; IMMUNOMODULATION; INFLAMMATION; INTRAOCULAR PRESSURE; KERATOCONJUNCTIVITIS SICCA; LASER THERMOTHERAPY; NAUSEA; NONHUMAN; RASH; REVIEW; SECONDARY INFECTION; SERUM; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; TREATMENT OUTCOME;

EID: 84859949340     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Behrens A, Doyle JJ, Stern L. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900-907.
2. Kaushik N, Syan N, Handa N, Mathur P, Kaushik P, Rani S. Perspective advancements in understanding and managing dry eye disease. Int J Pharm Sci Rev Res 2011;7 Suppl 1:100-105
3. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
4. Nguyen T, Latkany R. Review of Hydroxypropyl Cellulose ophthalmic inserts for treatment of dry eye. Clinical Ophthalmology 2011;5:587-591
5. Mishima S. Some physiological aspects of the precorneal tear film. Arch Ophthalmol 1965;73: 233.
6. Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001;45:211-220.
7. Lemp MA, Hamill JR. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol 1973;89:103.
8. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a 25-year review. Cornea 2000;19:644-649.
9. Jain MR. Dry Eye Syndrome: Emerging Challenge in Ophthalmology. Nutrition journal 2009:5-15.
10. Schaumberg DA, Sullivan DA, Buring JE. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-326.
11. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol 2004;122:369-373.
12. Gopal M, Varghese C. Dry Eye Syndrome: A Review. Journal of Clinical and Diagnosis Research 2007;1 Suppl 1:22-31.
13. Gupta MK, Mishra B, Prakash D, Rai SK. Nanoparticulate drug delivery system of cyclosporine. Int J Pharm Pharma Sci 2009;1(2):81-92
14. McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry 2009;80:555-566.
15. Guzey M, Karaman S, Satici A, Ozardali I, Sezer S, Bozkurt O, et al. Efficacy of Topical cyclosporine A in the treatment of severe trachomatous dry eye. Clin Exp Ophthalmol 2009;27: 541-549.
16. Stern M, Beuerman R, Fox R, Gao J, Mircheff A, Pflugfelder A. A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 1998;438:643-651.
17. Borel J, Baumann G, Chapman I, Donatsch P, Fahr A, Mueller E. In vivo pharmacological effects of cyclosporine and some analogues. Adv Pharmacol 1996;35:115-146.
18. Brignole F, Pisella PJ, Goldschild M. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41:1356-1363.
19. Gao J, Schwalb TA, Addeo JV. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy. Cornea 1998;17:654-663.
20. Strong B, Farley W, Stern ME. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 2005;24:80-85.
21. Pflugfelder SC. Anti-inflammatory therapy for dry eye. Am J Ophthalmol 2004;137:337-342.
22. Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y, et al. Sodium hyaluronate eye drops in the treatment of dry eyes. Br J Ophthalmol 1995;79:1007-1011.
23. Choy EPY, Cho P, Benzie IFF, Choy CKM. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM). Cornea 2006;25:1200-1204.
24. Zeilgs MA, Gordon K. Dehydroepiandrorterone therapy for the treatment of dry eye disorders. International Patient Application WO 94/04155. 1994.
25. Yang CQ, Sun W, Gu YS. A clinical study of the efficacy of topical corticosteroids on dry eye. J Zhejiang Univ Sci 2006;7:675-678.
26. Dry eye syndrome, managed care, published by MediMedia USA Inc., at 780 Township Line Road, Yardley PA 19067, 2003.
27. Medhat W, Laila H, Amany H, Amal A, Ghada G. Efficacy of topically applied liposome-bound tetracycline in the treatment of dry eye model. Veterinary Ophthalmology 2011;14 Suppl 1:19-20.
28. Sansom J, Barnett K, Newmann W, Schulte-Neumann A, Clerc B, Jegou J. Treatment of Keratoconjunctivits Sicca in dogs with cyclosporine ophthalmic ointment: A European clinical field trial. Vet Rec 1995;137:504-507.
29. Calonge M. The Treatment of Dry Eye. Surv Ophthalmol 2001;45 Suppl 2:227-239.
30. Wagh VD, Wagh KV, Inamdar B, Malay KS. The effect of forskolin ophthalmic inserts on intraocular pressure in rabbit eyes. Int J Pharm Pharma Sci 2009;1(2):147-155.
31. Nepp J, Derbolav A, Haslinger-Akramian J. Effect of acupuncture in keratoconjunctivitis sicca. Klin Monatsbl Augenheilkd 1999;215:228-232.
32. Fox RI, Chan R, Michelson JB. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-461.
33. Tsubota K, Fujishima H, Toda I. Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjogrens syndrome patients. Acta Ophthalmol Scand 1995;73:425-430.
34. Gilger BC, Rose PD, Davidson MG. Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs. J Interferon Cytokine Res 1999;19:901-905.
35. Burnjstein NL. Corneal cytotoxicity of topical applied drug, vehicles, and preservatives. Surv Ophthalmol 1980;25:15-29.
36. Steinfeld SD, Demols P, Van Vooren JP. Zidovidine in primary Sjogren syndrome. Rheumatology (oxford) 1999;38:814-817
37. Steinfeld SD, Demols P, Van Vooren JP. Zidovudine in primary Sjogrens syndrome. Rheumatology (Oxford) 1999;38:814-817.
38. Sahlin S, Chen E. Evaluation of the lacrimal drainage function by the drop test. Am J Ophthalmol 1996;122:701-708.
39. Sahlin S, Chen E, Kaugesaar T. Effect of eyelid botulinum toxin injection on lacrimal drainage. Am J Ophthalmol 2000;129:481-486.
40. Wagh VD, Inamdar B, Samanta MK. Polymers used in ocular dosage form and drug delivery systems. Asian J Pharm 2008;2:12-17
41. Murube J, Murube A, Zhuo C. Classification of artificial tears. II: Additives and commercial formulas. Adv Exp Med Biol 1998;438:705-715.
42. Murube J, Paterson A, Murube E. Classification of artificial tears. I: Composition and properties. Adv Exp Med Biol 1998;438:693-704.
43. Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomaterial Sci 2006;17 Suppl 3:247-289.
44. Das S, Sureshb PK, Desmukh CR. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomed Nanotech Biol and Med 2009.
45. Hornig S, Heinze T, Becer CR, Schubert US. Synthetic polymeric nanoparticles by nanoprecipitation. J Material Chem 2009;19:3838-3840.
46. Peltonen L, Aitta J, Hyvonen S, Karjalainen M, Hirvonen J. Improved Entrapment Efficiency of Hydrophilic Drug Substance During Nanoprecipitation of Poly(l)lactide Nanoparticles. AAPS PharmSciTech 2004;5 Suppl 1:115-120.
47. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57 Suppl 2:171-185.
48. Nanavaty MA, Vasavada AR, Gupta PD. Dry eye syndrome. Asian J Exp Sci 2006;20:63-80.
49. Nguyen T, Latkany R. Review of Hydroxypropyl Cellulose Ophthalmic Inserts For Treatment of Dry Eye. Clinical Ophthalmology 2011.
50. Maurice DM. The tonicity of an eye drop and its dilution by tears. Exp Eye Res 1971;11:30-33.
51. Schiffman RM, Christianson MD, Jacoksen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2002;118:615-621.
52. Pfister RR, Burnstein N. The effects of ophthalmic drugs, electron microscope study. Invest Ophthalmol 1976;15:246-259.
53. Burnjstein NL. Corneal cytotoxicity of topical applied drug, vehicles, and preservatives. Survey Ophthalmol 1980;25:15-29.
54. Vibhute S, Kawtikwar P, Kshirsagar S, Sakarkar D. Formulation and evaluation of tear substitutes. Int J Pharm Sci Rev and Res 2010;2 Suppl 1:17-20.
55. Gupta C, Chauhan A. Ophthalmic delivery of cyclosporine A by Punctal plugs. J Control Release 2011;150:70-76.
56. Tuberville AW, Frederick WR, Wood TO. Punctal occlusion in tear deficiency syndromes. Ophthalmology 1982;89:1170-1172.
57. Murube J, Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol 1996;40:463-480.
58. Murube J, Olivares C, Murube E. Treatment of dry eye by punctum patch. Orbit 1995;14:1-7.
59. Benson DR, Hemmady PB, Snyder RW. Efficacy of laser punctual occlusion. Ophthalmology 1992;99:618-621.
60. Glatt HJ. Acute dacryocystitis after punctal occlusion of keratoconjunctivitis sicca (letter). Am J Ophthalmol 1991;111:769-770.
61. Lamberts DW. Punctal occlusion. Int Ophthalmol Clin 1994;34:145-150.
62. Lemp MA. Management of the dry-eye patient. Int Ophthalmol Clin 1994;34:101-13.
63. Linberg JV, Moore CA. Symptoms of canalicular obstruction. Ophthalmology 1988;95:1077-1079.
64. Redmond JW. Punctal occlusion with collagen implants. Ophthalmic Surg 1992;23:642.
65. Willis RM, Folberg R, Krachmer JH, Holland EJ. The treatment of aqueous-deficient dry eye with removable punctual plugs: A clinical and impression-cytologic study. Ophthalmology 1987; 94:514-518.
66. Burgess P, Koay P, Clark P. Smart Plug versus silicone punctual plug therapy for dry eye: a prospective randomized trial. Cornea 2008;27:391-394.
67. Gupta C, Chauhan A. Ophthalmic delivery of cyclosporine A by punctal plugs. J Control Release 2011;150:70-76.
68. Gilbord JP, Kenyon KR. Tear diluents in the treatment of keratoconjunctivitis sicca. Ophthalmology 1985;92:646-650.
69. Kokke K, Morris J, Lawrenson J. Oral omega-6 essential fatty acids treatment in contact lense associated dry eye. CLAE 2008;31:141-146.
70. Bhavsar AS, Bhavsar SG, Jain SM. A review on recent advances in dry: pathogenesis and management. Oman J Ophthalmol 2011;4 Suppl 2:50-56.
71. Nanavaty MA, Vasavada AR, Gupta PD. Dry eye syndrome. Asian J Exp Sci 2006;20:63-80.
72. Blom M, Kopp S, Lundeberg T. Prognostic value of the pilocarpine test to identify patients who may obtain long term relief from xerostomia by acupuncture treatment. Arch Otolaryngol Head Neck Surg 1999;125:561-566.
73. Baldone JA, Kaufman HE. Extended wear contact lenses. Am J Ophthalmol 1983;15:595-596.
74. Farris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34:129-136.
75. Gilbard JP, Rossi SR, Heyda KG, Dartt DA. Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels. Invest Ophthalmol Vis Sci 1990;31:1381-1388.
76. Lemp MA. Management of the dry-eye patient. Int Ophthalmol Clin 1994;34:101-113.
77. Tsubota K. New approaches to dry-eye therapy. Int Ophthalmol Clin 1994;34:115-128.
78. Baldone JA, Kaufman HE. Extended wear contact lenses. Am J Ophthalmol 1983;15:595-596.
79. Farris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34:129-136.
80. Tsubota K. New approaches to dry-eye therapy. Int Ophthalmol Clin 1994;34:115-128.
81. Dhiman K.S. Shushkakshipaka (dry eye syndrome): A case study. Int J Ayurved Res 2011;2:53-55.